Loading…
Reported covered position: Associate Director, National Economic Council
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Ensuring Patient Access to Critical Breakthrough Products (S.1717) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness AI in Healthcare FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2025 · second_quarter · Q2
Ensuring Patient Access to Critical Breakthrough Products (S.1717) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness AI in Healthcare FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development
CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (s.1717) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development
Source: Senate LDA
CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (s.1717) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Ensuring Patient Access to Critical Breakthrough Products (H.R.1691 S.5349) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Ensuring Patient Access to Critical Breakthrough Products (H.R.1691 S.5349) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5439) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Cybersecurity for Healthcare Industry AI in Healthcare FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Drought Resilient Infrastructure Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5439) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Cybersecurity for Healthcare Industry AI in Healthcare FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5439) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1961) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1961) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development
Southern Utah Open OHV Areas Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1961) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development
Southern Utah Open OHV Areas Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1961) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Consolidated Appropriations Act, 2023
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Consolidated Appropriations Act, 2023
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Consolidated Appropriations Act, 2023
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Consolidated Appropriations Act, 2023
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Consolidated Appropriations Act, 2023
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Iran Responsible Reporting Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Consolidated Appropriations Act, 2023
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine) H.R.2617 - Consolidated Appropriations Act, 2023
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine) H.R.2617 - Consolidated Appropriations Act, 2023
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Meaningful Access to Federal Health Plan Claims Data Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Meaningful Access to Federal Health Plan Claims Data Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Meaningful Access to Federal Health Plan Claims Data Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Financial Literacy to Financial Freedom Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Whistleblower Protection Extension Act of 2017
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Iran Responsible Reporting Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Iran Responsible Reporting Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Iran Responsible Reporting Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Iran Responsible Reporting Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine) H.R.2617 - Consolidated Appropriations Act, 2023
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
National Aeronautics and Space Administration Authorization Act of 2018
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
Meaningful Access to Federal Health Plan Claims Data Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Meaningful Access to Federal Health Plan Claims Data Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
Meaningful Access to Federal Health Plan Claims Data Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
Meaningful Access to Federal Health Plan Claims Data Act of 2021
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
SUPPORT for Patients and Communities Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Corporate Tax Reform Proposals
Tariffs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2025 · first_quarter · Q1
Ensuring Patient Access to Critical Breakthrough Products (H.R.1691 S.5349) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development
CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development
Corporate Tax Reform Proposals
Tariffs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2024 · fourth_quarter · Q4
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Supply Chain Proposals
Corporate Tax Reform Proposals
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5439) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2024 · third_quarter · Q3
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Cybersecurity for Healthcare Industry AI in Healthcare FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
Corporate Tax Reform Proposals
Use of Ethylene Oxide in Medical Device Sterilization
Supply Chain Proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2024 · second_quarter · Q2
Use of Ethylene Oxide in Medical Device Sterilization
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1961) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
Corporate Tax Reform Proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2024 · first_quarter · Q1
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain Japan Reimbursement of Medical Devices
Use of Ethylene Oxide in Medical Device Sterilization
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2023 · second_quarter · 2A
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Use of Ethylene Oxide in Medical Device Sterilization
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2023 · fourth_quarter · Q4
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2023 · third_quarter · Q3
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain Japan Reimbursement of Medical Devices
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2023 · second_quarter · Q2
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain
Corporate Tax Reform Proposals
Dept. of Veterans Affairs TAVR Access
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2023 · first_quarter · Q1
Use of Ethylene Oxide in Medical Device Sterilization
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2022 · fourth_quarter · Q4
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine) H.R.2617 - Consolidated Appropriations Act, 2023
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2022 · third_quarter · Q3
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain
Use of Ethylene Oxide in Medical Device Sterilization
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2022 · second_quarter · Q2
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2022 · first_quarter · Q1
Use of Ethylene Oxide in Medical Device Sterilization
Supply Chain Proposals China Market Access and Supply Chain
Coronavirus Preparedness and Response Provisions Corporate Tax Reform Proposals
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2021 · fourth_quarter · Q4
Coronavirus Preparedness and Response Provisions Corporate Tax Reform Proposals
Use of Ethylene Oxide in Medical Device Sterilization
Supply Chain Proposals China Market Access and Supply Chain
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2021 · third_quarter · Q3
Use of Ethylene Oxide in Medical Device Sterilization
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2021 · second_quarter · Q2
Coronavirus Preparedness and Response Provisions Corporate Tax Reform Proposals
Supply Chain Proposals China Market Access and Supply Chain
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2021 · first_quarter · Q1
Use of Ethylene Oxide in Medical Device Sterilization
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (MCIT Proposed Rule) Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2020 · fourth_quarter · 4A
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (MCIT Proposed Rule) Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development
Coronavirus Preparedness and Response Provisions
Use of Ethylene Oxide in Medical Device Sterilization
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2020 · fourth_quarter · Q4
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (MCIT Proposed Rule) Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development
Coronavirus Preparedness and Response Provisions
Use of Ethylene Oxide in Medical Device Sterilization
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2020 · second_quarter · 2A
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Coronavirus Preparedness and Response Provisions
China Market Access and Supply Chain
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2020 · third_quarter · Q3
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (MCIT Proposed Rule) Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine) Health Equity Issues Coverage with Evidence Development
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2020 · second_quarter · Q2
Coronavirus Preparedness and Response Provisions
Use of Ethylene Oxide in Medical Device Sterilization
China Market Access and Supply Chain
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2020 · first_quarter · Q1
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 2207 Protect Medical Innovation (Device Tax Repeal) S. 692 (Medical Device Tax Repeal) Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees H.R. 6074/S. 3548 Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision H.R. 6074/S. 3548 Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2019 · fourth_quarter · Q4
Use of Ethylene Oxide in Medical Device Sterilization
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safe harbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
S. 692 (Medical Device Tax Repeal) H.R. 2207 Protect Medical Innovation (Device Tax Repeal)
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2019 · third_quarter · Q3
S. 692 (Medical Device Tax Repeal) H.R. 2207 Protect Medical Innovation (Device Tax Repeal)
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 2207 Protect Medical Innovation (Device Tax Repeal) S. 692 (Medical Device Tax Repeal) Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safe harbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2019 · first_quarter · 1A
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Protect Medical Innovation (Device Tax Repeal) S. 692 (Medical Device Tax Repeal) Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safe harbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2019 · second_quarter · Q2
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safe harbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
S. 692 (Medical Device Tax Repeal) H.R. 2207 Protect Medical Innovation (Device Tax Repeal)
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 2207 Protect Medical Innovation (Device Tax Repeal) S. 692 (Medical Device Tax Repeal) Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2019 · first_quarter · Q1
S. 692 (Medical Device Tax Repeal) Protect Medical Innovation (Device Tax Repeal)
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Protect Medical Innovation (Device Tax Repeal) S. 692 (Medical Device Tax Repeal) Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safe harbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2018 · fourth_quarter · 4A
H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communitties Act (Sunshine)
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2018 · fourth_quarter · Q4
H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2018 · third_quarter · Q3
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communitties Act (Sunshine)
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2018 · first_quarter · 1A
H.R. 195, Federal Register Printing Savings Act of 2017 (CR) Implementation of PL 115-97, Tax Cuts & Jobs Act H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA S. 149, Medical Device Access & Innovation Protection Act H.R. 195, Federal Register Printing Savings Act of 2017 (CR) Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430, FDA Reauthorization Act of 2017 S. 934, FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 Postmarket Surveillance Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2018 · second_quarter · Q2
H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Heart Valve Disease Awareness National Coverage Decision for TAVR Reporting of transfer of value to healthcare providers (Sunshine)
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA H.R.5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430, FDA Reauthorization Act of 2017 S. 934, FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act Postmarket Surveillance Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2018 · first_quarter · Q1
H.R. 195, Federal Register Printing Savings Act of 2017 (CR) Implementation of PL 115-97, Tax Cuts & Jobs Act Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Patent Box International Tax Issues H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness National Coverage Decision for TAVR
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2017 · fourth_quarter · 4A
Federal Corporate Tax Rate Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income International Tax Issues H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA S. 149, Medical Device Access & Innovation Protection Act Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430, FDA Reauthorization Act of 2017 S. 934, FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 Postmarket Surveillance H.R. 2144, Risk-Based Classification of Accessories Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2017 · fourth_quarter · Q4
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA S. 149, Medical Device Access & Innovation Protection Act Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430, FDA Reauthorization Act of 2017 S. 934, FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 Postmarket Surveillance H.R. 2144, Risk-Based Classification of Accessories Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
Federal Corporate Tax Rate Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income International Tax Issues H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2017 · third_quarter · 3A
Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Patent Box International Tax Issues H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA S. 149, Medical Device Access & Innovation Protection Act Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430, FDA Reauthorization Act of 2017 S. 934, FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 Postmarket Surveillance H.R. 2144, Risk-Based Classification of Accessories Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2017 · third_quarter · Q3
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA S. 149, Medical Device Access & Innovation Protection Act Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430, FDA Reauthorization Act of 2017 S. 934, FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 Postmarket Surveillance H.R. 2144, Risk-Based Classification of Accessories Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2017 · second_quarter · Q2
Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Patent Box International Tax Issues H.R. 184: Protect Medical Innovation Act of 2017 S. 108: Medical Device Access & Innovation Protection Act
Implementation of PL 114-255: 21st Century Cures Act Implementation of PL-111-148: PPACA S. 149, Medical Device Access & Innovation Protection Act Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430: FDA Reauthorization Act of 2017 S. 934: FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 Post-market Surveillance H.R. 2430: FDA Reauthorization Act of 2017 H.R. 2144: Risk-Based Classification of Accessories Act of 2017 H.R.1736: To amend the Federal Food, Drug, and Cosmetic Act S. 404: A bill to amend the Federal Food, Drug, and Cosmetic Act
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2017 · first_quarter · Q1
CMS Coverage Policies For Medical Devices CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness
H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance S. 404, FDA Inspection Process Heart Valve Disease Awareness
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 184, Protect Medical Innovation Act of 2017 Repatriation S. 108, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · fourth_quarter · 4A
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · fourth_quarter · Q4
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · third_quarter · Q3
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform International Tax Issues Treasury Anti-inversion Regulation Section 385
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · second_quarter · Q2
Domestic Manufacturing Credit Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · first_quarter · Q1
CMS Coverage Policies For Medical Devices Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices
Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R. 1, Tax Reform Act of 2014 Innovation Promotion Act of 2015 (Patent/Innovation Box draft legislation) Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Transfer Pricing
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · fourth_quarter · Q4
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
CMS Coverage Policies For Medical Devices CMS Payment Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · third_quarter · Q3
CMS Coverage Policies For Medical Devices CMS Payment Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014 Obama Administration 2016 Budget Proposals Senate Finance Committee Tax Reform Process
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · second_quarter · Q2
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate Innovation Initiative
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · first_quarter · Q1
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols 21st Century Cures and other Device Innovation Initiatives
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · fourth_quarter · Q4
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R. 523, Protect Medical Innovation Act of 2013 S. 232 Medical Device Access & Innovation Protection Act
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Medical Device Postmarket Surveillance H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013 Enhanced Surgical Recovery Protocols 21st Century Cures and other Device Innovation Initiatives
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · third_quarter · Q3
CMS Coverage Policies; CMS Payment Policies; Inpatient Prospective Payment System Proposed Rule;
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance; H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"; Enhanced Surgical Recovery Protocols; 21st Century Cures and other Device Innovation Initiatives;
Veteran Access to Transcatheter Heart Valve Therapies;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · second_quarter · Q2
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance; H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"; Enhanced Surgical Recovery Protocols; 21st Century Cures and other Device Innovation Initiatives;
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · first_quarter · Q1
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance;
CMS Coverage Policies; Medicare Payment Bundling Initiatives; CMS Payment Policies
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1961) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting Coverage with Evidence Development
Corporate Tax Reform Proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Corporate Tax Reform Proposals
Dept. of Veterans Affairs TAVR Access
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Corporate Tax Reform Proposals
Use of Ethylene Oxide in Medical Device Sterilization
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain Japan Reimbursement of Medical Devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Use of Ethylene Oxide in Medical Device Sterilization
Dept. of Veterans Affairs TAVR Access
Corporate Tax Reform Proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Use of Ethylene Oxide in Medical Device Sterilization
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Corporate Tax Reform Proposals
Dept. of Veterans Affairs TAVR Access
Supply Chain Proposals The CHIPS Act of 2022 China Market Access and Supply Chain
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Transitional Coverage for Emerging Technologies (TCET) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development H.R.2617 - Consolidated Appropriations Act, 2023
Use of Ethylene Oxide in Medical Device Sterilization
Corporate Tax Reform Proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Coronavirus Preparedness and Response Provisions (PHE) Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Corporate Tax Reform Proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Supply Chain Proposals China Market Access and Supply Chain
Corporate Tax Reform Proposals
Use of Ethylene Oxide in Medical Device Sterilization
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Inspection Modernization Emerging Signals Shortage Reporting S.3799 PREVENTS Pandemic Act Coverage with Evidence Development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) Medicare Coverage for Innovative Technologies (MCIT) rule Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 1193, The Cardiovascular Advances in Research and Opportunities Legacy Act CAROL Act Coverage with Evidence Development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.4043) (includes MCIT Proposed Rule) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions Health Equity Issues Coverage with Evidence Development HR 5394 Registry Access to Medicare Claims Data includes Coverage with Evidence Development provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Supply Chain Proposals China Market Access and Supply Chain
Coronavirus Preparedness and Response Provisions Corporate Tax Reform Proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Use of Ethylene Oxide in Medical Device Sterilization
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (MCIT Proposed Rule) Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Implementation of PL 114-10, MACRA FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions Health Equity Issues Cures 2.0 Draft Registry Access to Medicare Claims Data Coverage with Evidence Development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Coronavirus Preparedness and Response Provisions Corporate Tax Reform Proposals
Supply Chain Proposals China Market Access and Supply Chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine) Health Equity Issues Coverage with Evidence Development
China Market Access and Supply Chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
China Market Access and Supply Chain
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine) Health Equity Issues Coverage with Evidence Development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions
Use of Ethylene Oxide in Medical Device Sterilization
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Coronavirus Preparedness and Response Provisions
Use of Ethylene Oxide in Medical Device Sterilization
China Market Access and Supply Chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry FDA Reauthorization for 2022/FDA User Fees Coronavirus Preparedness and Response Provisions
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Ensuring Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision Coronavirus Preparedness and Response Provisions H.R. 6, SUPPORT For Patients and Communities Act (Sunshine)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 6074/S. 3548 Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 692 (Medical Device Tax Repeal) H.R. 2207 Protect Medical Innovation (Device Tax Repeal)
China Market Access
Use of Ethylene Oxide in Medical Device Sterilization
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA Ensuring Patient Access to Critical Breakthrough Products Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 2207 Protect Medical Innovation (Device Tax Repeal) S. 692 (Medical Device Tax Repeal) Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
S. 692 (Medical Device Tax Repeal) Protect Medical Innovation (Device Tax Repeal)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Heart Valve Disease Awareness National Coverage Decision for TAVR H.R. 6, SUPPORT For Patients and Communitties Act (Sunshine)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness National Coverage Decision for TAVR
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA S. 149, Medical Device Access & Innovation Protection Act H.R. 195, Federal Register Printing Savings Act of 2017 (CR) Policies promoting medical innovation Heart Valve Disease Awareness H.R. 2430, FDA Reauthorization Act of 2017 S. 934, FDA Reauthorization of 2017 H.R. 184, Protect Medical Innovation Act of 2017 Postmarket Surveillance Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Patent Box International Tax Issues H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies For Medical Devices Implementation of PL 114-255: 21st Century Cures Act CMS Payment Policies for Medical Devices Antikickback Statute Safeharbors Patient Access to Critical Breakthrough Products Heart Valve Disease Awareness
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies CMS Payment Policies H.R. 6, 21st Century Cures Act Senate Innovation Initiative
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies CMS Payment Policies 21st Century Cures and other Device Innovation Initiatives
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies CMS Payment Policies 21st Century Cures and other Device Innovation Initiatives
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies; CMS Payment Policies; Inpatient Prospective Payment System Proposed Rule; Post Acute Transfer Policy;
Veteran Access to Transcatheter Heart Valve Therapies;
Japan Foreign Average Pricing Policy;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE